Development and Validation of a Stability-Indicating RP-HPLC Method for the Simultaneous Determination of Sofosbuvir, Velpatasvir, and Voxilaprevir in Tablet Formulation

Deepthi R; Gowri Sankar D

Authors

Deepthi R
Gowri Sankar D

Keywords:

stabilityindicating, method development, validation, RP-HPLC, sofosbuvir

Abstract

Abstract not found

Downloads

How to Cite

Development and Validation of a Stability-Indicating RP-HPLC Method for the Simultaneous Determination of Sofosbuvir, Velpatasvir, and Voxilaprevir in Tablet Formulation. (2020). Global Journal of Medical Research, 20(B3), 7-14. https://medicalresearchjournal.org/index.php/GJMR/article/view/2007

Download Citation

References

Sandhya Rani, J Devanna, N (2018) Development and validation of RP-HPLC method for the simultaneous estimation of Sofosbuvir, velpatasvir, and voxilaprevir in bulk and tablet dosage forms. 11(2), 452-459.

Sandhya Rani, J Devanna, N (2017) New RP-HPLC method development and validation for simultaneous estimation of sofosbuvir and velpatasvir in a pharmaceutical dosage form. 4(11), 145-152.

Geetha Susmitha, A Rajitha, G (2018) Development and validation of stability indicating UPLC method for simultaneous estimation of sofosbuvir and velpatasvir in a tablet dosage form. 9(11), 4764-4769.

Lakshmana Rao, A Pallavi, A (2019) Method Development and Validation of Stability Indicating RP-HPLC Method for Simultaneous Estimation of Sofosbuvir and Velpatasvir in Tablet Dosage Form. 2(1), 1-8.

B; Balaswami, P Ramana, ; Venkata, B Rao, P Subba; Sanjeeva (2018) A New Simple Stability-Indicating RP-HPLC-PDA Method for Simultaneous Estimation of Triplicate Mixture of Sofosbuvir, Velpatasvir, and Voxilaprevir in Tablet Dosage Form. 11(9), 4147-4156.

Memthoibi Devi, L, Dr Rama Mohan Reddy, T Dr, K Abbulu (2010) Simultaneous determination and validation of third generation antiviral drugs by RP-HPLC method. 8(1), 1-8.

K Lalitha, Raveendra Reddy, J Devanna, N (2018) Stability indicating RP-HPLC method development and validation for estimation of Sofosbuvir in a pharmaceutical dosage form. 7(5), 656-662.

Phillip Borman, David Elder (2005) Q2(R1) Validation of Analytical Procedures. 127-166.

(1996) ICH: Q2B. Harmonized Tripartite Guideline, Validation of Analytical Procedure: Methodology, IFPMA.

G Ngwa (2010) Forced degradation studies as an integral part of HPLC stability indicating method development. 10, 56-59.